Mesh Bio News Today

The patent gives virtual assistant clients access to the digital twins of human experts.

The California-based company will put the funds toward its workforce, growing its data and further investing in R&D initiatives and engineering capabilities.

This comes three months after getting regulatory approval from Singapore’s Health Sciences Authority for its latest digital twin solution.

Mesh Bio on Wednesday raised $3.5 million in funding to double down on its digital twin technology, which produce virtual models, or “twins,” of a patient’s state of health based on their data.

Mesh Bio, a Singapore-based health deep tech startup, has raised $3.5m in its Series A funding round anchored by existing investor East Ventures.

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

Mesh Bios funding round led by East Ventures will enable the scaling of deployment around Southeast Asia.

The California-based company will use the funds to expand its Whole Body Twin Technology aimed at preventing and reversing metabolic disease.

Also, DeepTek has obtained another 510(k) from the US FDA for its AI solution.

Bringing you the latest news briefs on fundraising activities in the Asia Pacific.